Cafepharma Today

September 20 2017 - Pfizer files lawsuit against JNJ over Remicade biosimilar

Pfizer files lawsuit against JNJ over anticompetitive practices related to Remicade biosimilar, Alnylam’s RNAi drug shines in trial, new Teva CEO Schultz getting lots of advice, and more - scroll down for the latest news

Embed from Getty Images

Today's most popular searches:

For banking news and anonymous forums, be sure to check out cafebanking.com

Current News

With help from J&J, upstart Provention lands rights to two mid-stage IBD drugs and shoots for PhII
Endpoints
Thursday, September 21, 2017 - 8:49am
tags:
JNJ, Provention Bio, IBD, inflammatory bowel disease, PRV-6527, Crohn's Disease, PRV-300, ulcerative colitis
Venturing Boldly Into Neuroscience
Forbes
Thursday, September 21, 2017 - 8:47am
tags:
startups, Neuroscience, Disarm Therapeutics, Rodin Therapeutics, Lysosomal Therapeutics
Nestle plans to ax hundreds of R&D staffers, shutter big dermatology campus
Endpoints
Thursday, September 21, 2017 - 8:45am
tags:
R&D, layoffs, Galderma, Nestle, dermatology
Merck KGaA, Pfizer's cancer drug Bavencio gets EU nod
Yahoo/Reuters
Thursday, September 21, 2017 - 8:38am
tags:
Bavencio, Europe, Merck KGaA, Pfizer, Merkel cell carcinoma
This squabble between two big drugmakers could have major implications for the U.S. health care system
Marketwatch
Thursday, September 21, 2017 - 8:36am
tags:
JNJ, Pfizer, antitrust, biosimilars, Remicade, Inflectra
Former Lawyer Sues Synthetic Genomics “Boys Club” over Gender Bias
Xconomy
Thursday, September 21, 2017 - 8:33am
tags:
Synthetic Genomics, gender discrimination
Fifth Circuit Upholds Summary Judgement for Solvay Pharmaceuticals in Off-Label and Anti-Kickback FCA Case
FDA Law Blog
Thursday, September 21, 2017 - 8:32am
tags:
Solvay, kickbacks, False Claims Act, off-label
3 Ways AI Is Changing Medicine
Motley Fool
Thursday, September 21, 2017 - 8:30am
tags:
artificial intelligence, Gritstone Oncology, Alphabet, cancer immunotherapy, IBM Watson, Pfizer, Google Brain, diabetes, retinal blindness, HeartFlow, Verily
2 Important Dates for Big Pharma
Yahoo/GuruFocus
Wednesday, September 20, 2017 - 11:15pm
tags:
Merck, Keytruda, Bristol-Myers Squibb, Opdivo
FDA: 30 Percent of Drugs Used in Expanded Access Programs are Later Approved
RAPS.org
Wednesday, September 20, 2017 - 11:13pm
tags:
FDA, expanded access programs, drug approvals
FDA’s Janet Woodcock: the clinical trials system is ‘broken’
Endpoints
Wednesday, September 20, 2017 - 11:10pm
tags:
FDA, Janet Woodcock, clinical trials
Pfizer leads Big Pharma's emerging markets growth as GlaxoSmithKline, Eli Lilly lag
Fierce Pharma
Wednesday, September 20, 2017 - 11:08pm
tags:
Pfizer, GSK, Eli Lilly, emerging markets
After settling with the SEC, biotech VC Steven Burrill now faces up to 30 years for fraud, tax evasion charges
Endpoints
Wednesday, September 20, 2017 - 11:07pm
tags:
Steven Burrill, venture capital, tax evasion, fraud
Judge denies PhRMA, BIO jab at Nevada law
BioPharma Dive
Wednesday, September 20, 2017 - 11:05pm
tags:
PhRMA, BIO, Nevada, drug pricing
Pfizer files US lawsuit against Johnson & Johnson over "anticompetitive" practices related to Remicade biosimilar
First Word Pharma
Wednesday, September 20, 2017 - 11:03am
tags:
Pfizer, JNJ, Janssen, Remicade, biosimilars, Inflectra
Finn's new 'social impact' PR practice aims to help pharma do well by doing good
Fierce Pharma
Wednesday, September 20, 2017 - 10:51am
tags:
pharma industry, philanthropy, social responsibility, sustainability
New Guidelines Address CAR-T Immunotherapy Toxicities to Prevent Patient Deaths
Xtalks
Wednesday, September 20, 2017 - 10:41am
tags:
CAR-T, Juno Therapeutics, Kite Pharma, Cellectis
Sanofi’s Elias Zerhouni says his R&D group is ready to stand alone — but big M&A and partnerships still loom large
Endpoints
Wednesday, September 20, 2017 - 10:36am
tags:
Sanofi, R&D, M&A
Alnylam’s rare disease drug shines in trial, paving way for a brand-new class of medicines
Stat
Wednesday, September 20, 2017 - 9:27am
tags:
Alnylam, rare disease, Patisiran, familial amyloid polyneuropathy, RNAi
Teva CEO gets lots of advice on how to fix beleaguered company, even before he begins
Fierce Pharma
Wednesday, September 20, 2017 - 9:24am
tags:
Teva Pharmaceutical, Pharma CEOs, Kåre Schultz
From big biopharma to biotech CEO, John Houston’s R&D journey highlights a fast-changing world
Endpoints
Wednesday, September 20, 2017 - 9:23am
tags:
R&D, John Houston, Big Pharma, biotech, Arvinas, GSK, Bristol-Myers Squibb
Apple Likes the Patent ‘Death Squad.’ Allergan Pays to Avoid It
Bloomberg
Wednesday, September 20, 2017 - 9:14am
tags:
Allergan, Apple, patents, Restasis
Remicade: A Case Study in How U.S. Pricing and Reimbursement Curb Adoption of Biosimilars
Drug Channels
Wednesday, September 20, 2017 - 9:05am
tags:
drug pricing, reimbursement, Remicade, biosimilars, Janssen, Inflectra, Pfizer, Renflexis, Merck
FDA Warns Korean, Chinese Drugmakers
RAPS.org
Wednesday, September 20, 2017 - 9:02am
tags:
FDA, warnings, China, Korea, drug manufacturing
Drug Industry Denied Fast Relief in Nevada Price Law Challenge
Bloomberg
Tuesday, September 19, 2017 - 10:47pm
tags:
drug pricing, Nevada
States Push Ahead With Investigation Into Opioid Painkillers
FOX Business
Tuesday, September 19, 2017 - 10:41pm
tags:
opioids, opioid crisis, Endo International, Janssen, Allergan, Teva Pharmaceutical, Purdue Pharma
Troubled Teva turns to risk-sharing team at Nuvelution to gamble on a new PhIII study
Endpoints
Tuesday, September 19, 2017 - 10:28pm
tags:
Teva Pharmaceutical, Nuvelution, R&D
Medtech complaint handling: Is there something to complain about?
Medical Design and Outsourcing
Tuesday, September 19, 2017 - 10:26pm
tags:
devices, complaints
AbbVie, Roche to seek broader market for leukemia drug after trial success
BioPharma Dive
Tuesday, September 19, 2017 - 10:23pm
tags:
AbbVie, Roche, clinical trials, Venclexta, Rituxan, chronic lymphocytic leukemia
GlaxoSmithKline, needing a sales surge, wins FDA nod for $1B-plus prospect Trelegy
Fierce Pharma
Tuesday, September 19, 2017 - 10:21pm
tags:
GSK, FDA, Trelegy Ellipta, COPD

Latest Pharmagather Articles

New FDA Directions – Part 3 – Opioids
eye on fda
3 Ways to How Social Media Marketing Is Useful in the Healthcare Industry
Digital Pharma Blog
Alnylam Breaks Through
In the Pipeline
Bacteria Can Make Tumors Worse
In the Pipeline
Remicade: A Case Study in How U.S. Pricing and Reimbursement Curb Adoption of Biosimilars
Drug Channels
Tie Your Crystals Into Knots
In the Pipeline
CBI’s Gross-to-Net Summit
Drug Channels
The Ugly State of the Literature These Days
In the Pipeline
Weekly Roundup 9.15.17
eye on fda

Latest CP Wire Articles

Fewer pharma job cuts so far in 2017
How Are Whistleblowers Paid
Proove Biosciences Responds to News About FBI Raid
Tips for Your Next Job Interview
UroToday.com, Leading Urology Reference Site, Launches a New Clinical Trials Portal
Physician-Rep Conversation - A Lesson From Cafepharma
MedReps Survey Reveals Best Places to Work in Medical Sales in 2017 (inc. infographic)
Using Real World Evidence to Drive Affordability of Specialty Drugs
Novartis Social Media Network for Patients - Is This a Good Idea
Risk on the Front Line: Tips for Managing Sales Force Liability
Pharma Jobs from Indeed

CP Wire

Submit an article to cafepharma's CP Wire. Click here to find out more.

Pharma and Device News from NASDAQ

ProQR Presents in vivo Proof of Concept Data for the Axiomer® RNA Editing Platform Technology
Thursday, September 21, 2017 - 7:05am
ProQR to Present at Two Investor Conferences in September
Thursday, September 21, 2017 - 7:00am
Oxygen Concentrators and Cylinders Market worth over $4.5 billion by 2024: Global Market Insights, Inc.
Thursday, September 21, 2017 - 7:00am
BioCryst’s RAPIVAB® (peramivir injection) Receives FDA Approval for a Pediatric Indication
Thursday, September 21, 2017 - 6:00am
Amarin to Present at Cantor Global Healthcare Conference
Wednesday, September 20, 2017 - 4:30pm
Arbutus’ LNP Licensee Alnylam Announces Positive Phase 3 Results for LNP-Enabled Patisiran Program
Wednesday, September 20, 2017 - 12:22pm
Lightstone Ventures Closes New Life Sciences Fund at $250 Million
Wednesday, September 20, 2017 - 7:27am
Achillion to Present at the 2017 Leerink Partners Rare Disease Roundtable Series
Wednesday, September 20, 2017 - 6:05am
Iovance Biotherapeutics, Inc. Announces Public Offering of Common Stock
Tuesday, September 19, 2017 - 4:35pm
Novavax to Present at the Ladenburg Thalmann 2017 Healthcare Conference
Tuesday, September 19, 2017 - 4:05pm

Breaking Healthcare News - powered by Seeking Alpha

Phase 1/2 study underway on Audentes' AT132 in rare inherited muscle disorder; shares up 2%
Thursday, September 21, 2017 - 10:03am
FDA OK's Perrigo's generic Exalgo
Thursday, September 21, 2017 - 9:46am
FDA advisory committee to meet November 7 on development plan for Pfizer's staph vaccine
Thursday, September 21, 2017 - 9:35am
Cellectar Bio teams up with Onconova to develop PDCs; shares ahead 4% premarket
Thursday, September 21, 2017 - 9:26am
MiMedx responding to SEC subpoena related to whistleblower allegations, says revenue recognition policies proper
Thursday, September 21, 2017 - 9:18am
Endologix announces CE Mark approval for the Nellix EndoVascular Aneurysm Sealing System with the refined IFU
Thursday, September 21, 2017 - 8:47am
Paratek's omadacycline granted additional QIDP status in U.S.
Thursday, September 21, 2017 - 8:40am
Abiomed receives FDA PMA approval for Impella RP for right heart failure; shares ahead 2% premarket
Thursday, September 21, 2017 - 8:32am
Updated labeling for Gilead's Epclusa OK'd in Canada
Thursday, September 21, 2017 - 8:18am
Genetic Technologies transitions to online commercial platform for BREVAGenplus
Thursday, September 21, 2017 - 8:15am

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.